Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) EBT Margin (2020 - 2022)

Historic EBT Margin for Immuneering (IMRX) over the last 3 years, with Q4 2022 value amounting to 2960184.4%.

  • Immuneering's EBT Margin fell 29543967400.0% to 2960184.4% in Q4 2022 from the same period last year, while for Sep 2023 it was 11588326.59%, marking a year-over-year decrease of 115787957500.0%. This contributed to the annual value of 15937.29% for FY2022, which is 143101800.0% down from last year.
  • Per Immuneering's latest filing, its EBT Margin stood at 2960184.4% for Q4 2022, which was down 29543967400.0% from 33781.04% recorded in Q3 2022.
  • Immuneering's EBT Margin's 5-year high stood at 644.49% during Q3 2020, with a 5-year trough of 2960184.4% in Q4 2022.
  • Its 3-year average for EBT Margin is 274998.48%, with a median of 1768.4% in 2021.
  • Its EBT Margin has fluctuated over the past 5 years, first plummeted by -4606200bps in 2021, then tumbled by 2000000000bps in 2022.
  • Over the past 3 years, Immuneering's EBT Margin (Quarter) stood at 877.48% in 2020, then tumbled by -560bps to 5787.65% in 2021, then plummeted by -51047bps to 2960184.4% in 2022.
  • Its EBT Margin stands at 2960184.4% for Q4 2022, versus 33781.04% for Q3 2022 and 12183.19% for Q2 2022.